Corporate report: MHRA Women’s Health Programme 2026-2030
Safety Classified by Officially
Our Strategy to 2030 sets out how to deliver health and prosperity for all, through scientific excellence. One of our strategic priorities within this strategy is to deliver proactive regulation to address evidence gaps and reduce inequalities.
This is an extract. The publication continues at the source.
Contains public sector information licensed under the Open Government Licence v3.0. Licence
Read the original at the source: https://www.gov.uk/government/publications/mhra-womens-health-programme-2026-2030
Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Medicines and Healthcare products Regulatory Agency — imported from official source
- Official source
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
- Imported
- November 16, 2026 09:00
- Versions
- 1 recorded
- Identity
-
https://www.gov.uk/government/publications/mhra-womens-health-programme-2026-2030#2026-...